Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David S. Gordon, MD
Aronex Pharmaceuticals
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
59 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Veterans Affairs Medical Center - Phoenix (hayden)
Phoenix, Arizona, United States
- Holt-Krock Clinic
Fort Smith, Arkansas, United States
- Arkansas Children'S Hospital
Little Rock, Arkansas, United States
- Office of Rosalda Rodriguez, M.D.
Chula Vista, California, United States
- Beckman Research Institute, City of Hope
Duarte, California, United States
- Eisenhower Medical Center
Rancho Mirage, California, United States
- University of Colorado Cancer Center
Denver, Colorado, United States
- New Britain General Hospital
New Britain, Connecticut, United States
- Vincent T. Lombardi Cancer Research Center, Georgetown University
Washington D.C., District of Columbia, United States
- Sylvester Cancer Center, University of Miami
Miami, Florida, United States
- Tampa Children'S Hospital
Tampa, Florida, United States
- Rush-Presbyterian-St. Luke'S Medical Center
Chicago, Illinois, United States
- St. John'S Pavilion - Springfield Clinic Research Department
Springfield, Illinois, United States
- University of Kansas Medical Center
Kansas City, Kansas, United States
- Lake Charles Medical and Surgical Clinic
Lake Charles, Louisiana, United States
- Johns Hopkins Oncology Center
Baltimore, Maryland, United States
- Boston University School of Medicine
Boston, Massachusetts, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Barbara Ann Karmanos Cancer Institute
Detroit, Michigan, United States
- Henry Ford Hospital
Detroit, Michigan, United States
- United Hospital
Saint Paul, Minnesota, United States
- Columbia Comprehensive Cancer Care Clinic
Columbia, Missouri, United States
- University of Missouri-Columbia Hospital and Clinics
Columbia, Missouri, United States
- Antibiotic Research Associates
Kansas City, Missouri, United States
- Children'S Mercy Hospital - Kansas City
Kansas City, Missouri, United States
- Veterans Affairs Medical Center - Kansas City
Kansas City, Missouri, United States
- University of Nebraska Medical Center
Omaha, Nebraska, United States
- Hackensack University Medical Center
Hackensack, New Jersey, United States
- Jersey Shore Cancer Center
Neptune City, New Jersey, United States
- Riverview Medical Center
Red Bank, New Jersey, United States
- Brooklyn Hospital Center
Brooklyn, New York, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- Long Island Jewish Medical Center
New Hyde Park, New York, United States
- St. Vincent'S Medical Center of Richmond
Staten Island, New York, United States
- Albert Einstein Comprehensive Cancer Center
The Bronx, New York, United States
- Duke Comprehensive Cancer Center
Durham, North Carolina, United States
- Brookview Research, Inc.
Winston-Salem, North Carolina, United States
- Comprehensive Cancer Center of Wake Forest University Baptist Medical Center
Winston-Salem, North Carolina, United States
- Summa Health System
Akron, Ohio, United States
- Cleveland Clinic Cancer Center
Cleveland, Ohio, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 1996
- Primary completion
- —
- Completion
- 30 Sept 2007
- Last update posted
- 26 Mar 2013
- Registered enrollment
- —
- Registry id
- NCT00002742
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.